Original Research
Accepted on 21 Feb 2025
Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer: A Phase 1b Study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1555921
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,287 articles
Articles
Study Protocol
Accepted on 20 Feb 2025
Efficacy of Thunder-Fire Moxibustion for Cancer-Related Fatigue in Breast Cancer Survivors: Study Protocol for a Randomized Controlled Trial
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1496741
Case Report
Published on 20 Feb 2025
Breast acinic cell carcinoma with weak progesterone receptor expression: a case report and literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1497272
- 118 views
Original Research
Published on 18 Feb 2025
Identification of benign and malignant breast nodules on ultrasound: comparison of multiple deep learning models and model interpretation
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1517278
- 142 views
Original Research
Accepted on 17 Feb 2025
De-escalation of Regional Nodal Irradiation Fields in pT1-2N1 Breast Cancer Patients after Breast Conserving Surgery: Retrospective Real-world Clinical Experience
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1484190
Mini Review
Published on 17 Feb 2025
Bisphenol A and DDT disrupt adipocyte function in the mammary gland: implications for breast cancer risk and progression
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1490898
- 108 views
Original Research
Accepted on 14 Feb 2025
Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1459444
Systematic Review
Accepted on 13 Feb 2025
A Meta-analysis and Systematic review of Different Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1472407
Review
Accepted on 13 Feb 2025
Mechanisms, Assessment, and Exercise Interventions for Skeletal Muscle Dysfunction Post-Chemotherapy in Breast Cancer: From Inflammation Factors to Clinical Practice
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1551561
Review
Accepted on 13 Feb 2025
A Case of High-Grade Adenosquamous Carcinoma of the Breast: Case Report and Literature Review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1548036
Systematic Review
Accepted on 13 Feb 2025
PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1540538
Original Research
Published on 11 Feb 2025
Combined morphology and radiomics of intravoxel incoherent movement as a predictive model for the pathologic complete response before neoadjuvant chemotherapy in patients with breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1452128
- 226 views
Case Report
Published on 11 Feb 2025
Case report: Unraveling a unique case of male occult breast cancer with axillary intricacies and a comprehensive literature dive
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1374032
- 225 views
Correction
Accepted on 07 Feb 2025
Corrigendum: The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1536374
Review
Accepted on 06 Feb 2025
Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2-advanced/metastatic breast cancer: Updated systematic review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1530391
Original Research
Published on 06 Feb 2025
The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1402300
- 164 views